During the past decade, considerable progress has been made in unraveling the
pathogenesis of pulmonary hypertension. Primary (unexplained) pulmonary hypertension …

Primary pulmonary hypertension (PPH) is a rare disorder with an incidence of one to two
cases per million people per year in Western populations. It is a progressive disease usually …

The past two decades has seen remarkable advances in the understanding of the basic
biology of various forms of pulmonary hypertension as well as the development of much …

The clinical importance of pulmonary hypertension is largely a function of the burden that it
imposes on the right ventricle. In principle, pulmonary hypertension should be easier to treat …

Pulmonary hypertension (PH) is an area of clinical medicine and medical science that is
exemplary in many aspects, with tremendous progress having been made in a relatively …

The last 2 generations of physicians and researchers in pulmonary hypertension (PH) have
undergone their training, performed investigations, and practiced without a thorough …

Despite major advances in our understanding of the pathophysiologic processes leading to
pulmonary arterial hypertension and recent developments in therapeutic approaches, the …

Pulmonary hypertension (PH) refers to an increase in pulmonary arterial pressure, defined
as mean pulmonary artery pressure (mPAP) Z25 mmHg at rest, that if left untreated may …

Pulmonary hypertension comprises a family of disorders occurring as a primary disease or
as a complication of a large number of respiratory and cardiac diseases. Pulmonary …

Pulmonary artery hypertension secondary to chronic lung diseases is a clinical entity with no
specific symptoms that can develop as a result of parenchymal lung disorders (COPD …